Influence of portal vein and liver artery ligation on the toxicokinetics of soman in rabbits

Toxicology Letters

Volumn 135, Issue 1-2, 2002, Pages 73-78

  Li, Jin Tong ^a   Ruan, Jin Xiu ^a   Zhang, Zhen Qing ^a   Yuan, Shu Lan ^a   Song, Zheng Yan ^a   Han, Dong ^b  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b NONE   (China)

Author keywords

Detoxification; Elimination; Intestine; Liver; Soman; Toxicokinetics

Indexed keywords

SOMAN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTERY LIGATION; ARTICLE; HEPATIC ARTERY; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RABBIT; TOXICOKINETICS; VEIN LIGATION;

ANIMALS; AREA UNDER CURVE; CHOLINESTERASE INHIBITORS; FEMALE; HEPATIC ARTERY; LIGATION; LIVER; PORTAL VEIN; RABBITS; SOMAN; STEREOISOMERISM;

ORYCTOLAGUS CUNICULUS;

EID: 0037026714     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00235-7     Document Type: Article

References (13)

1. Benschop H.P., Koningas C.A.G., Van Genderen J., De Jong L.P.A. Isolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman. Toxicol. Appl. Pharmacol. 72:1984;61-74.
2. Benschop H.P., De Jong L.P.A. Toxicokinetics of soman: species variation and stereospecificity in elimination pathways. Neurosci. Biobehav. Rev. 15:1991;73-77.
3. Clement J.H. Role of aliesterase in organophosphate poisoning. Fundam. Appl. Toxicol. 4:1984;96-105.
4. De Jong L.P.A., Van Duk C., Benschop H.P. Hydrolysis of four and stereoisomers of soman catalyzed by liver homogenates and plasma from rat, guinea pig and marmoset, and by human plasma. Biochem. Pharmacol. 37:1988;2939-2948.
5. De Jong L.P.A., Van Duk C., Berhitoe D., Benschop H.P. Hydrolysis and binding of a toxic stereoisomers of soman in plasma and tissue homogenates from rat, guinea pig and marmoset, and in human plasma. Biochem. Pharmacol. 46:1993;1413-1419.
6. Due A.H., Trap H.C., Langenberg J.P., Benschop H.P. Toxicokinetics of soman stereoisomers after subcutaneous administration to atropinized guinea pigs. Arch. Toxicol. 68:1994;60-63.
7. Kentera D., Susic D., Stamenovic B. The effect of HS-3 and HS-6 on cardiovascular changes in caused by soman. Arh. Hig. Rada. Toksikol. 33:1982;143-150.
8. Langenberg J.P., Dijk C.V., Sweeney R.E., Mexwell D.M., De Jong L.P.A., Benschop H.P. Development of a physiologically based model for the toxicokinetics of C(±)P(±)-soman in the atropinized guinea pig. Arch. Toxicol. 71:1997;320-333.
9. Langenberg J.P., Spruit H.E., Van der Wiel H.J., Trap H.C., Helmich R.B., Bergers W.W.A., Van Helden H.P.M., Benschop H.P. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose - only exposure to soman vapor. Toxicol. Appl. Pharmacol. 151:1998;79-87.
10. Li J.-T., Ruan J.-X., Yuan S.-L., Zhang Z.-Q., Song Z.-Y. Gas chromatographi analysis of the stereoisomers of soman and its toxicokinetics in rabbit’s blood. Chin. J. Pharm. Toxicol. 15:2001;458-461. In Chinese.
11. Maxwell D.M., Lenz D.E., Groff W.A., Kaminskii A., Froehlich H. The effects of blood flow and detoxification in vivo cholinesterase inhibition by soman in rats. Toxicol. Appl. Pharmacol. 88:1987;66-76.
12. Maxwell D.M. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol. 114:1992;306-312.
13. Worek F., Szinicz L. Analysis of cardiovascular and respiratory effects of various doses of soman in guinea-pigs: efficacy of atropine treatment. Arch Int. Pharmacodyn. Ther. 325:1993;96-112.